Skip to content
AnalystLens

AGILENT TECHNOLOGIES, INC. Annual Report, Year Ended Oct 31, 2011

Filing Date
Filed December 16, 2011
Period End
October 31, 2011
Security
A
One revenue dollarkept$0.15
In the record · 2016–202610-K1010-Q338-K115

A filed 10 annual reports (10-K), 33 quarterly reports (10-Q) and 115 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Jul ’17Jul ’17
  2. Material agreement8-K · Oct ’19Oct ’19
  3. Leadership change8-K · Dec ’21Dec ’21
  4. Leadership change8-K · Oct ’25Oct ’25

01—Abstract

Summary

Summary of the 10-K filed December 16, 2011. Cited figures are marked; the original filing is the authoritative source.

Agilent Technologies, Inc. reported a strong fiscal year ended October 31, 2011, with net revenue increasing by 22% to $6.615 billiona.

This growth was significantly bolstered by the acquisition of Varian, Inc. in May 2010, which contributed approximately 5 percentage points to the revenue increase after accounting for divested businesses. The company's net income saw a substantial rise to $1.012 billionb from $684 million in the prior year, reflecting improved operating results and effective management of expenses. The company's performance was driven by broad-based improvements across its three key business segments: Life Sciences, Chemical Analysis, and Electronic Measurement.

The Life Sciences segment experienced a 21% revenue increase, supported by strong performance in LC-MS and genomics products, while the Chemical Analysis segment grew 27%, driven by demand in petrochemical and food safety markets. The Electronic Measurement segment saw a 19% revenue increase, with strong performance in both general-purpose and communications test markets. Agilent ended the fiscal year with a healthy cash position of $3.5 billionc, indicating sound financial management.

The company continued its investment in research and development, demonstrating a commitment to innovation and future growth. Looking ahead, Agilent remains focused on integrating its acquisitions, driving cost synergies, and expanding its market presence, particularly in emerging markets.

02—Key points

Key Highlights

  1. Net revenue increased by 22% to $6.615 billion for the fiscal year ended October 31, 2011.
  2. Net income rose significantly to $1.012 billion, up from $684 million in the previous year.
  3. The acquisition of Varian, Inc. in May 2010 was a key driver of growth, contributing approximately 5% to the revenue increase.
  4. All three business segments – Life Sciences, Chemical Analysis, and Electronic Measurement – showed robust revenue growth.
  5. The company ended the fiscal year with strong liquidity, holding $3.527 billion in cash and cash equivalents.
  6. Operating income from operations for the electronic measurement business saw a significant increase of 74% year-over-year.
  7. Agilent maintained its commitment to R&D, with expenditures of $649 million for the fiscal year.

03—One dollar

Follow one dollar

Of each $1.00 of revenue in FY2011, Agilent Technologies, Inc. kept $0.15.

  1. Revenue$6.62B100.0%
  2. Cost of revenue−$3.09B46.7%
  3. Gross profit$3.53B53.3%
  4. Operating costs−$2.46B37.2%
  5. Operating income$1.07B16.2%
  6. Interest, other & tax−$59.0M0.9%
  7. Net income$1.01B15.3%
Computed from 10-KFY2011filed December 16, 2011Computed from this filing’s revenue, gross profit, operating income and net income · right columngrey figure: share of revenue

Where FY2011 revenue went

$6.62B
  • Cost of revenue: $3.09B, 47% of revenue
  • SG&A: $1.81B, 27% of revenue
  • Net income: $1.01B, 15% of revenue
  • R&D: $649.0M, 9.8% of revenue
  • Interest, other & tax: $59.0M, 0.9% of revenue

Kept 15% as net incomeInterest, other & tax $59.0M · 0.9%

Full revenue history →

04—Financials

Financial Highlights

Figures from 10-KFY2011filed December 16, 2011
Revenue$6.62B53.3% Gross MarginNet Income$1.01B15.3% Net MarginEPS (Diluted)$2.85Total Assets$9.06BCash & Equivalents$3.53BFree Cash Flow$1.07B

Financial Statements

FY2011 against FY2010

Line itemFY2011FY2010Change
Revenue$6.62B$5.44B+21.5%
Cost of Revenue$3.09B$2.51B+22.8%
Gross Profit$3.53B$2.93B+20.4%
R&D Expenses$649.00M$612.00M+6.0%
SG&A Expenses$1.81B$1.75B+3.3%
Operating Expenses$5.54B$4.88B+13.7%
Operating Income$1.07B$566.00M+89.2%
Interest Expense$86.00M$96.00M−10.4%
Net Income$1.01B$684.00M+48.0%
EPS (Basic)$2.92$1.97+48.2%
EPS (Diluted)$2.85$1.94+46.9%
Shares Outstanding (Basic)347.00M347.00M0.0%
Shares Outstanding (Diluted)355.00M353.00M+0.6%

05—Questions

Frequently Asked Questions

  1. What was Agilent's overall financial performance in fiscal year 2011?

    Agilent reported strong financial performance in fiscal year 2011, with net revenue growing 22% to $6.615 billion and net income increasing to $1.012 billion. This growth was driven by the acquisition of Varian, Inc. and solid performance across all business segments.

  2. How did the Varian acquisition impact Agilent's results?

    The acquisition of Varian, Inc. in May 2010 was a significant factor in Agilent's 2011 results. It contributed approximately 5 percentage points to the revenue growth and expanded Agilent's portfolio, particularly in life sciences and chemical analysis, while also leading to an increase in goodwill and acquired intangible assets.

  3. What is Agilent's current financial health and liquidity position?

    Agilent demonstrated strong financial health and liquidity, ending fiscal year 2011 with $3.527 billion in cash and cash equivalents. The company also has a $400 million unsecured credit facility available. Operating cash flow was robust at $1.260 billion.

  4. How did each of Agilent's business segments perform?

    All three segments performed well: Life Sciences revenue grew 21%, Chemical Analysis revenue grew 27%, and Electronic Measurement revenue grew 19%. This growth was supported by new product introductions and market demand, with significant contributions from the Varian integration.

06—Continue

← View all 10-K filings